Cannasat changes name to Cynapsus Therapeutics

Cannasat Therapeutics (TSX-V:CTH) received shareholder approval to change its corporate name to Cynapsus Therapeutics, with no change to the stock symbol.

In a statement, CEO Anthony Giovinazzo said the new name, which is drawn loosely from the word “synapse,” more accurately reflects the company’s new focus and direction on treatments for central nervous system diseases and away from a narrow concentration on cannabinoid drug candidates.